Syndax Pharmaceuticals (NASDAQ:SNDX) CEO Sells $2,581,407.87 in Stock - MarketBeat
3 hours ago • Google News
Syndax Pharmaceuticals Inc (SNDX)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 1.34B
P/E Ratio
0.00
Revenue (TTM)
$ 77.93M
Volume
0
52W High
$ 22.50
52W Low
$ 8.58
Dividend Yield
0.00%
Beta
0.72
Technicals
50-Day MA
12.7519
200-Day MA
12.836
52 Week High
22.5
52 Week Low
8.58
About SNDX
Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.
Employees
270
Headquarters
New York, NY
CEO
Mr. Michael A. Metzger M.B.A.
Latest News
Syndax resumed with Buy at Stifel on newly launched drugs - Seeking Alpha
3 days ago • Google News
When Will Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Turn A Profit? - simplywall.st
6 days ago • Google News